Alps Advisors Inc Meridian Bioscience Inc Transaction History

Alps Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$17.35 - $22.5 $241,182 - $312,772	-13,901 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$19.76 - $29.89 $68,073 - $102,971	-3,445 Reduced 19.86%	13,901 $365,000
Q4 2020 Feb 03, 2021	SELL	$15.73 - $21.66 $5,552 - $7,645	-353 Reduced 1.99%	17,346 $324,000
Q3 2020 Nov 04, 2020	BUY	$13.54 - $26.41 $239,644 - $467,430	17,699 New	17,699 $301,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.